Syros Pharmaceuticals, Inc. (SYRS)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
Oct 6, 2025, 2:41 PM EDT
Syros Pharmaceuticals Market Cap
Syros Pharmaceuticals has a market cap or net worth of $134.16 thousand as of October 6, 2025. Its market cap has decreased by -99.75% in one year.
Market Cap
134.16K
Enterprise Value
2.09M
Revenue
386.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since June 30, 2016, Syros Pharmaceuticals's market cap has decreased from 413.10M to 134.16K, a decrease of -99.97%. That is a compound annual growth rate of -57.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 134.16K | -97.82% |
| Dec 31, 2024 | 6.17M | -96.96% |
| Dec 29, 2023 | 202.59M | 179.01% |
| Dec 30, 2022 | 72.61M | -64.04% |
| Dec 31, 2021 | 201.95M | -59.37% |
| Dec 31, 2020 | 497.05M | 69.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |